tiprankstipranks
Advertisement
Advertisement

ALXO Stock Latest News

ALX Oncology appoints Jeff Knight as chief development, operating officer
The FlyALX Oncology appoints Jeff Knight as chief development, operating officer
16d ago
ALXO
CRNX
ALX Oncology Appoints Jeff Knight to Lead Development
PremiumCompany Announcements
ALX Oncology Appoints Jeff Knight to Lead Development
16d ago
8K
ALXO
ALX Oncology initiated with an Overweight at Wells Fargo
PremiumThe Fly
ALX Oncology initiated with an Overweight at Wells Fargo
1M ago
ALXO
Alx Oncology Faces Renewed Nasdaq Listing Risk After Prior Minimum Bid Price Violation
PremiumCompany Announcements
Alx Oncology Faces Renewed Nasdaq Listing Risk After Prior Minimum Bid Price Violation
2M ago
ALXO
ALX Oncology price target raised to $4 from $2 at H.C. Wainwright
PremiumThe Fly
ALX Oncology price target raised to $4 from $2 at H.C. Wainwright
2M ago
ALXO
Alx Oncology Earnings Call Highlights Biomarker Momentum
PremiumCompany AnnouncementsAlx Oncology Earnings Call Highlights Biomarker Momentum
2M ago
ALXO
ALX Oncology initiated with a Buy at UBS
Premium
The Fly
ALX Oncology initiated with a Buy at UBS
2M ago
ALXO
ALX Oncology reports Q4 EPS (42c), consensus (36c)
Premium
The Fly
ALX Oncology reports Q4 EPS (42c), consensus (36c)
2M ago
ALXO
ALXO Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ALXO Earnings this Week: How Will it Perform?
2M ago
ALXO
ALX Oncology price target raised to $4 from $3 at Piper Sandler
PremiumThe Fly
ALX Oncology price target raised to $4 from $3 at Piper Sandler
3M ago
ALXO
ALX Oncology announces major underwritten public equity offering
PremiumCompany Announcements
ALX Oncology announces major underwritten public equity offering
3M ago
8K
ALXO
ALX Oncology Highlights Biomarker Data and Cash Position
PremiumCompany Announcements
ALX Oncology Highlights Biomarker Data and Cash Position
3M ago
8K
ALXO
ALX Oncology announces new data from Phase 1b/2 trial of evorpacept, Ziihera
PremiumThe FlyALX Oncology announces new data from Phase 1b/2 trial of evorpacept, Ziihera
3M ago
ALXO
JAZZ
ALX Oncology Expands Inducement Equity Plan for Hiring
Premium
Company Announcements
ALX Oncology Expands Inducement Equity Plan for Hiring
3M ago
8K
ALXO
ALX Oncology first patient dosed in Phase 2 ASPEN-09-Breast trial
Premium
The Fly
ALX Oncology first patient dosed in Phase 2 ASPEN-09-Breast trial
4M ago
ALXO
ALX Oncology announces data from Phase 2 trial of evorpacept
PremiumThe Fly
ALX Oncology announces data from Phase 2 trial of evorpacept
5M ago
ALXO
ALX Oncology initiated with a Buy at Jefferies
PremiumThe Fly
ALX Oncology initiated with a Buy at Jefferies
6M ago
ALXO
ALX Oncology Holdings: Buy Rating Backed by Promising Clinical Data and Strategic Initiatives
PremiumRatings
ALX Oncology Holdings: Buy Rating Backed by Promising Clinical Data and Strategic Initiatives
6M ago
ALXO
Alx Oncology Earnings Call: Optimism Amid Challenges
PremiumCompany Announcements
Alx Oncology Earnings Call: Optimism Amid Challenges
6M ago
ALXO
ALX Oncology Reports Promising Q3 2025 Results
PremiumCompany AnnouncementsALX Oncology Reports Promising Q3 2025 Results
6M ago
ALXO
ALX Oncology reports Q3 EPS (41c), consensus (37c)
Premium
The Fly
ALX Oncology reports Q3 EPS (41c), consensus (37c)
6M ago
ALXO
ALX Oncology sees cash runway into 1Q27
Premium
The Fly
ALX Oncology sees cash runway into 1Q27
6M ago
ALXO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >